Avalo Therapeutics Inc (AVTX) Live Share Price, Invest From India

Avalo Therapeutics Inc Stock Performance

as on November 15, 2025 at 2:29 am IST

Day's Low
Day's High
$14.04
Day's Price Range
$15.61
$15.17
7.45%
Downside
2.90%
Upside
52 Week's Low
52 Week's High
$3.39
52-Week Price Range
$19.41
$15.17
77.65%
Downside
27.95%
Upside

Avalo Therapeutics Inc share price movements today

Previous Close: $14.73
Open: $14.37
Volume: 636.6K
Day's Low - High: $14.04 - $15.61
52 Week Low - High: $3.39 - $19.41

Avalo Therapeutics Inc Historical Returns

1 Month Return: + 5.29 %
3 Month Return: + 64.58 %
1 Year Return: + 9.27 %
3 Year Return: -98.94 %
5 Year Return: 0 %

Avalo Therapeutics Inc Stock Fundamentals & Key Indicators

Check Avalo Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$279.8M

EPS (TTM)

-6.778

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

PEG Ratio

EBITDA

-66.1M

Revenue (TTM)

192.0K

Profit Margin

0.00%

Return On Equity TTM

-174.79%

Avalo Therapeutics Inc Stock Valuation

Track how Avalo Therapeutics Inc P/E has moved over time to understand its valuation trends.

Avalo Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-172.90x)

June 30, 2022

Industry (0.00x)

November 14, 2025

Today (-0.07x)

November 14, 2025

Highest (-0.02x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.07x

Avalo Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Avalo Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Avalo Therapeutics Inc	SELL	$279.8M	NA	-0.07	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$59.8B	235.01%	1414.81	1.36%
Beone Medicines Ltd	NA	$40.9B	NA	712.21	1.38%
Vertex Pharmaceuticals Incorporated	BUY	$110.2B	92.67%	30.58	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$71.6B	22.7%	16.34	32.13%

Stock Returns calculator for Avalo Therapeutics Inc Stock including INR - Dollar returns

The Avalo Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Avalo Therapeutics Inc investment value today

Current value as on today

₹1,17,779

Returns

₹17,779

(+17.78%)

Returns from Avalo Therapeutics Inc Stock

₹12,537 (+12.54%)

Dollar Returns*

₹5,242 (+5.24%)

Analyst Recommendation on Avalo Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Avalo Therapeutics Inc. Average target price of $33.71

Avalo Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Avalo Therapeutics Inc.

What analysts predicted

55%UPSIDE

Target Price

$33.71

Current Price

$15.17

Analyzed by

6 Analysts

Target

$33.71

Avalo Therapeutics Inc target price $33.71, a slight upside of 55% compared to current price of $15.17. According to 6 analysts rating.

Avalo Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Avalo Therapeutics Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 17, 2025 to November 16, 2025

Change:-63% versus previous 30 day period

Avalo Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	-	-	0	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	0	-
Operating Income	-7	-3	-3	-5	-9	-12	-13	-14	-19	-19
EBITDA	-7	-3	-8	-5	-9	-12	-13	-14	-19	-30
Interest Expense	0	1	0	-	1	0	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-5	-8	-121	98	23	-35	-13	-20	-30
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-8	-5	-8	-121	98	23	-35	-13	-20	-30
Net Profit Margin	-1274.18%	-2215.25%	-1430.47%	0.00%	0.00%	9251.81%	-18405.73%	0.00%	0.00%	0.00%

Avalo Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	27	18	6	6	5	18	1	0
Gross Profit	-7	27	10	7	6	3	14	0	0
Operating Income	-16	13	-39	-16	-26	-82	-37	-27	-68
EBITDA	-16	14	-13	-13	-45	-80	-37	-23	-68
Interest Expense	0	0	0	2	39	2	4	3	3
Depreciation	-	0	4	3	1	1	0	0	0
Income Before Tax	-16	13	-40	-15	-67	-84	-41	-31	-35
Income Tax Expense	0	1	0	0	-2	0	0	0	0
Net Income	-16	11	-40	-16	-63	-84	-41	-31	-35
Net Profit Margin	-1428.53%	42.68%	-218.55%	-238.10%	-947.90%	-1563.10%	-230.78%	-1639.50%	-7965.76%

Avalo Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-5	-8	-121	98	23	-35	-13	-20	-30
Operating Cash Flow	-6	-2	-6	-16	-11	-15	-9	-11	-16
Investing Cash Flow	-	0	-	0	-	-	-	-70	-13
Financing Cash Flow	10	0	108	0	-	67	-	0	14
Change in Cash	3	-2	102	-16	-11	52	-9	-82	-15

Avalo Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	11	-40	-16	-63	-84	-41	-31	-35
Operating Cash Flow	-14	12	-3	-19	-40	-70	-26	-30	-49
Investing Cash Flow	0	-18	0	0	11	0	0	0	0
Financing Cash Flow	-1	3	10	12	44	106	-14	25	175
Change in Cash	-16	-2	8	-7	15	35	-41	-5	127

Global Institutional Holdings in Avalo Therapeutics Inc

Funds	Holdings
Bvf Inc	7.82%
Nantahala Capital Management, LLC	7.57%
Orbimed Advisors, LLC	7.35%
RA Capital Management, LLC	7.09%
Affinity Asset Advisors, LLC	4.62%

See all

Insights on Avalo Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, AVTX stock has moved up by 67.5%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 71.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.8% return, outperforming this stock by 176.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 571.0K → 192.0K (in $), with an average decrease of 39.6% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -13.14M → -30.62M (in $), with an average decrease of 52.7% per quarter

About Avalo Therapeutics Inc

cerecor inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human brain. we are a delaware corporation, organized in april 2011 in partnership with various laboratories and research institutes at johns hopkins medical institute ("jhmi"). cerecor is focused on translational medicine – the accelerated transfer of technology from the academic laboratory to early human trials, with the goal of rapid commercialization. we acquire rights to early stage therapeutic technologies ("assets") from universities, finance and manage the development of these assets into drug candidates (to first major milestone or value inflection point) and then either commercialize or outlicense the asset.

Organisation	Avalo Therapeutics Inc
Headquarters	540 Gaither Road, Rockville, MD, United States, 20850
CEO	Dr. Garry A. Neil M.D.
E-voting on shares	Click here to vote

Key Management of Avalo Therapeutics Inc

Name	Title
Mr. Paul C. Varki J.D., M.P.H	Chief Legal Officer
Ms. Ashley Ivanowicz	Senior Vice President of Human Resources
Dr. Garry A. Neil M.D.	President, CEO & Director
Mr. Christopher Ryan Sullivan CPA	CFO & Head of Investor relations
Dr. Mittie Doyle FACR, M.D.	Chief Medical Officer
Dr. Solomon H. Snyder M.D.	Founder and Chairman of Scientific Advisory Board
Dr. Barbara S. Slusher Ph.D.	Founder and Member of Scientific Advisory Board

FAQs

What is Avalo Therapeutics Inc share price today?

Avalo Therapeutics Inc share price today is $15.17 as on November 15, 2025 at 2:29 am IST at the close of the market. Avalo Therapeutics Inc share today touched a day high of $15.61 and a low of $14.04.

What is the 52 week high and 52 week low for Avalo Therapeutics Inc share?

Avalo Therapeutics Inc share touched a 52 week high of $19.41 on October 21, 2025 and a 52 week low of $3.39 on May 14, 2025. Avalo Therapeutics Inc stock price today i.e. November 15, 2025 at 2:29 am IST is closed at $15.17,which is 21.84% down from its 52 week high and 347.49% up from its 52 week low.

What is Avalo Therapeutics Inc's market capitalisation today?

Avalo Therapeutics Inc market capitalisation is $0.00T as on November 15, 2025 at 2:29 am IST.

How to invest in Avalo Therapeutics Inc Stock (AVTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Avalo Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avalo Therapeutics Inc Shares that will get you 0.0989 shares as per Avalo Therapeutics Inc share price of $15.17 per share as on November 15, 2025 at 2:29 am IST.

What is the minimum amount required to buy Avalo Therapeutics Inc Stock (AVTX) from India?

Indian investors can start investing in Avalo Therapeutics Inc (AVTX) shares with as little as ₹88.74 or $1 (as of November 16, 2025 at 10:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Avalo Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on November 16, 2025 at 10:42 pm IST). Based on Avalo Therapeutics Inc share’s latest price of $15.17 as on November 15, 2025 at 2:29 am IST, you will get 0.6592 shares of Avalo Therapeutics Inc. Learn more about fractional shares .